Mylan to buy MS drug marketing rights from Israel's…
By Tamara MathiasApril 10 (Reuters) – Mylan NV will buy global marketing rights to an experimental multiple sclerosis treatment from Israel’s Mapi Pharma,… Via: Mylan to buy MS drug marketing rights from Israel's…